CBA were obviously happy with the product and service output of BOOM2 trials, so now are in pilot phase in which they will test capacity. Thus if they are stress testing IAMs capacity constraints, we are in for a big quarter of revenue. And not at discount. Go back and read the investor presentation, IAMs full price is already heavily discounted compared to industry standard costing. CBA cannot truely evaluate cost vs benefit if the pilots are not performed under standard process conditions and price.
CBA were obviously happy with the product and service output of...
-
- There are more pages in this discussion • 167 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add CF1 (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
2.2¢ |
Change
0.002(10.0%) |
Mkt cap ! $12.49M | |||
| Open | High | Low | Value | Volume |
| 2.0¢ | 2.2¢ | 2.0¢ | $36.83K | 1.750M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 1662472 | 2.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 2.2¢ | 211200 | 1 |
View Market Depth
| Last trade - 16.10pm 28/06/2024 (20 minute delay) ? |
| CF1 (ASX) Chart |